A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit

European Journal of Heart Failure

Volumn 10, Issue 8, 2008, Pages 740-748

  Chen, Ching Yi ^a   Lee, Bai Chin ^b   Hsu, Hsiu Ching ^b   Lin, Hung Ju ^b   Chao, Chia Lun ^b   Lin, Yen Hung ^b   Ho, Yi Lwun ^b   Chen, Ming Fong ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antioxidative defence; Coronary ligation; Myocardial infarction; Rabbit; Ramipril

Indexed keywords

CATALASE; CYCLOPHILIN A; FATTY ACID BINDING PROTEIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEAT SHOCK PROTEIN 27; HYDROXYPROLINE; RAMIPRIL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE COURSE; DOWN REGULATION; DRUG EFFICACY; ENZYME REGULATION; GENERAL CONDITION IMPROVEMENT; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEART VENTRICLE REMODELING; HEART WEIGHT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; RABBIT; RECOMMENDED DRUG DOSE; TRANSTHORACIC ECHOCARDIOGRAPHY; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CATALASE; CYCLOPHILIN A; DOWN-REGULATION; ECHOCARDIOGRAPHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FATTY ACID-BINDING PROTEINS; GLUTATHIONE PEROXIDASE; HEART VENTRICLES; HSP27 HEAT-SHOCK PROTEINS; HYDROXYPROLINE; MALE; MASS SPECTROMETRY; MYOCARDIAL INFARCTION; RABBITS; RAMIPRIL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE VOLUME; SUPEROXIDE DISMUTASE; UP-REGULATION; VENTRICULAR REMODELING;

EID: 46849110186     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.06.001     Document Type: Article

References (39)

1. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115 (2005) 500-508
2. Grieve D.J., Byrne J.A., Cave A.C., and Shah A.M. Role of oxidative stress in cardiac remodelling after myocardial infarction. Heart Lung Circ 13 (2004) 132-138
3. Murdoch C.E., Zhang M., Cave A.C., and Shah A.M. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 71 (2006) 208-215
4. Abunasra H.J., Smolenski R.T., Morrison K., et al. Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury. Eur. J. Cardio-Thorac. Surg. 20 (2001) 153-158
5. Shiomi T., Tsutsui H., Matsusaka H., et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109 (2004) 544-549
6. Koulouris S., Symeonides P., Triantafyllou K., et al. Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus. Am J Cardiol 95 (2005) 1386-1388
7. Liu Y.H., Yang X.P., Sharov V.G., et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 99 (1997) 1926-1935
8. Sebekova K., Gazdikova K., Syrova D., et al. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products. J Hum Hypertens 17 (2003) 265-270
9. Keidar S., Attias J., Coleman R., Wirth K., Scholkens B., and Hayek T. Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin. J Cardiovasc Pharmacol 35 (2000) 64-72
10. Kjoller-Hansen L., Steffensen R., and Grande P. Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure. J Am Coll Cardiol 37 (2001) 1214-1220
11. Chen M.F., Hsu H.C., and Lee Y.T. Effects of fish oil supplementation on the changes in myocardial cyclic adenosine monophosphate, inositol 1,4,5-triphosphate and mitochondrial calcium levels during acute coronary occlusion-reperfusion in cholesterol-fed rabbits. Int J Cardiol 46 (1994) 23-31
12. Reddy G.K., and Enwemeka C.S. A simplified method for the analysis of hydroxyproline in biological tissues. Clin biochem 29 (1996) 225-229
13. Chen M.F., Hsu H.C., and Lee Y.T. Short-term treatment with low-dose pravastatin attenuates oxidative susceptibility of low-density lipoprotein in hypercholesterolemic patients. Cardiovasc Drugs Ther 11 (1997) 787-793
14. Hsu H.C., Lee Y.T., and Chen M.F. Effects of fish oil and vitamin E on the antioxidant defense system in diet-induced hypercholesterolemic rabbits. Prostaglandins Other Lipid Mediat 66 (2001) 99-108
15. Johansson L.H., and Borg L.A. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174 (1988) 331-336
16. Wheeler C.R., Salzman J.A., Elsayed N.M., Omaye S.T., and Korte Jr. D.W. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 184 (1990) 193-199
17. Chen C.Y., Lee C.M., Hsu H.C., Yang C.Y., Chow L.P., and Lee Y.T. Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell. Life Sci 80 (2007) 2469-2480
18. Mellin V., Isabelle M., Oudot A., et al. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure. Eur Heart J 26 (2005) 1544-1550
19. Theres H., Wagner K.D., Schulz S., et al. Oxygen radical system in chronic infarcted rat heart: the effect of combined beta blockade and ACE inhibition. J Cardiovasc Pharmacol 35 (2000) 708-715
20. Hornig B., Landmesser U., Kohler C., et al. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103 (2001) 799-805
21. Forbes J.M., Cooper M.E., Thallas V., et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51 (2002) 3274-3282
22. Cherubini A., Ruggiero C., Polidori M.C., and Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 39 (2005) 841-852
23. Tsutamoto T., Wada A., Matsumoto T., et al. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J Am Coll Cardiol 37 (2001) 2086-2092
24. Walter M.F., Jacob R.F., Jeffers B., et al. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 44 (2004) 1996-2002
25. Qin F., Liang M.C., and Liang C.S. Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits. Biochim Biophys Acta 1740 (2005) 499-513
26. Qin F., Shite J., and Liang C.S. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol 285 (2003) H822-H832
27. Azzazy H.M., Pelsers M.M., and Christenson R.H. Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. Clin Chem 52 (2006) 19-29
28. Schaap F.G., Binas B., Danneberg H., van der Vusse G.J., and Glatz J.F. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 85 (1999) 329-337
29. Nielsen S.U., and Spener F. Fatty acid-binding protein from rat heart is phosphorylated on Tyr19 in response to insulin stimulation. J Lipid Res 34 (1993) 1355-1366
30. Widstrom R.L., Norris A.W., and Spector A.A. Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein. Biochemistry 40 (2001) 1070-1076
31. Baykan M., Celik U., Orem A., et al. Iron status and its relationship with lipid peroxidation in patients with acute myocardial infarction. Acta Cardiol 56 (2001) 277-281
32. Tanonaka K., Toga W., Yoshida H., and Takeo S. Myocardial heat shock protein changes in the failing heart following coronary artery ligation. Heart Lung Circ 12 (2003) 60-65
33. Dohke T., Wada A., Isono T., et al. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Card Fail 12 (2006) 77-84
34. Wellner M., Dechend R., Park J.K., et al. Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics 20 (2005) 256-267
35. Jin Z.G., Melaragno M.G., Liao D.F., et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 87 (2000) 789-796
36. Seko Y., Fujimura T., Taka H., Mineki R., Murayama K., and Nagai R. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 317 (2004) 162-168
37. Jin Z.G., Lungu A.O., Xie L., Wang M., Wong C., and Berk B.C. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol 24 (2004) 1186-1191
38. Kim H., Kim W.J., Jeon S.T., et al. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin Immunol 116 (2005) 217-224
39. Kim S.H., Lessner S.M., Sakurai Y., and Galis Z.S. Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 164 (2004) 1567-1574